Executive Director, Global New Assets Diagnostics Marketing, Precision Medicine

Merck•North Wales, PA

7d•Hybrid

About The Position

Our company’s Oncology organization is dedicated to delivering breakthrough innovations that extend and improve the lives of cancer patients worldwide. Our team of forward-thinking individuals achieve this through an unwavering commitment to support accessibility to medicine, providing new therapeutic solutions, and collaborating with governments and payers to ensure that people who need medicines have access to them. Our focus is on innovation and launch execution excellence; we translate breakthrough science into innovative medicines that help people with cancer across the globe. We are currently recruiting for an Executive Director, Global New Assets Diagnostics Marketing, Precision Medicine. The successful candidate will be charged with leading a team of experienced precision medicine directors and overseeing the development and implementation of commercial diagnostic strategies to advance key pipeline assets with biomarker and diagnostic associated indications. The candidate will work in close collaboration with Asset and Tumor Leads in Global Oncology Marketing, our Regional & Local Marketing Organizations, as well as the Diagnostic Development Teams in our Research Laboratories to ensure cross functional alignment through clinical development and successful commercial implementation. Close collaboration with multiple internal stakeholders across functions as well as external partners (diagnostic & device technology companies, reference laboratories, etc.) is fundamental to the success of the role. The role requires a proven track record in leadership and development of strategy, thinking creatively and shaping of diagnostics solutions in a dynamic business environment. Strategic vision, strategy creation, execution, strong financial understanding/acumen are imperative skills to the success of the role. The Executive Director will report to the Associate Vice President, Precision Medicine New Assets, Alliances, Digital Pathology, & ctDNA and will be a key member of our Global Precision Medicine Marketing teams. The ideal candidate is proactive, structured and exemplifies our inclusive ways of working; contributing to the development of evolving commercial models that ultimately create value for patients, laboratorians, payers and Healthcare Providers (HCPs).

Requirements

Minimum of 10 years of experience in pharmaceutical & diagnostic marketing, with a strong focus on oncology
Experience in launch preparation & global roll out of diagnostics & Precision Medicine solutions
Deep scientific understanding of molecular targets and diagnostic technologies
Proven ability to work with many areas of marketing management including strategy development, competitive dynamics, and issues management in a highly complex and dynamic environment.
Partner with clinical development team and external Dx partners to further refine target product profile and Go-to-market strategy
Exceptional communication and interpersonal skills to collaborate effectively with internal and external stakeholders.
Partner with clinical development team and external Dx partners to further refine target product profile and Go-to-market strategy
Bachelor's Degree

Nice To Haves

MSc, PhD or MBA

Responsibilities

Develop and Execute precision medicine product strategy and diagnostic Go-to-market plan to support the development & launch of our Oncology New Assets.
Provide commercial diagnostic oversight and input on diagnostic target product profile development, partner selection, market research, business cases, etc.
Provide input into short & long-term Business Strategy, Planning & Forecasting; lead & guide development of diagnostic strategies & tactics, positioning, messaging etc.
Provide commercial leadership, support and expertise to Diagnostic Development Teams, Global Brand Teams, Regional & Local Marketing Organizations
Collaborate with diagnostic partners as well as medical affairs teams to develop robust scientific communications and educational plans for Diagnostic tools supporting our oncology portfolio.
Partner with clinical development team and external Dx partners to further refine target product profile and Go-to-market strategy
Partner with clinical development team and external Dx partners to further refine target product profile and Go-to-market strategy